Notably, in colorectal cancer patients, the KRAS codon 12 mutation rate in cell-free DNA is significantly higher than that in healthy subjects.38 Our research concerning the evaluation of RAS gene status revealed a statistically significant association (p = 0.01) between KRAS status and gastric cancer. This evidence concerns the gene KRAS and colorectal cancer.